Discovery of an Aurora kinase inhibitor through site-specific dynamic combinatorial chemistry

Bioorg Med Chem Lett. 2008 Jul 15;18(14):3978-81. doi: 10.1016/j.bmcl.2008.06.011. Epub 2008 Jun 10.

Abstract

We demonstrate a fragment-based lead discovery method that combines site-directed ligand discovery with dynamic combinatorial chemistry. Our technique targets dynamic combinatorial screening to a specified region of a protein by using reversible disulfide chemistry. We have used this technology to rapidly identify inhibitors of the drug target Aurora A that span the purine-binding site and the adaptive pocket of the kinase. The binding mode of a noncovalent inhibitor has been further characterized through crystallography.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aurora Kinases
  • Binding Sites / drug effects
  • Chemistry, Pharmaceutical / methods*
  • Combinatorial Chemistry Techniques / methods*
  • Crystallography, X-Ray
  • Drug Design
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / chemistry*
  • Ligands
  • Mass Spectrometry / methods
  • Models, Chemical
  • Molecular Structure
  • Protein Serine-Threonine Kinases / antagonists & inhibitors*
  • Purines / chemistry
  • Structure-Activity Relationship

Substances

  • Enzyme Inhibitors
  • Ligands
  • Purines
  • Aurora Kinases
  • Protein Serine-Threonine Kinases
  • purine